InvestorPlace - Stock Market News, Stock Advice & Trading Tips
JPMorgan told clients to "underweight" Clover Health after the Medicare management firm lowered most guidance metrics. It knocked the CLOV stock price target down to $9 a share.
The post CLOV Stock: Why One Analyst Is Now Souring on Clover Health appeared first on InvestorPlace.
More From InvestorPlace